bezafibrate has been researched along with Myositis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hohendorff, B; Mühldorfer-Fodor, M; Prommersberger, KJ; Schmitt, R; Wagner, M | 1 |
Dann, EJ; Eisenberg, S; Eliav, O; Leitersdorf, E; Meiner, V; Muratti, EN; Peters, TK; Sehayek, E; Stein, Y | 1 |
Slobodin, G; Yeshurun, D | 1 |
Daher, E; Dakak, N; Khoury, K; Yeshurun, D | 1 |
1 trial(s) available for bezafibrate and Myositis
Article | Year |
---|---|
Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
Topics: Adult; Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heterozygote; Humans; Hyperlipoproteinemia Type II; Indoles; Male; Middle Aged; Myositis; Placebos; Safety; Single-Blind Method; Triglycerides | 1994 |
3 other study(ies) available for bezafibrate and Myositis
Article | Year |
---|---|
[Focal myositis as a side effect of antilipidemics - 2 patients with involvement of the forearm].
Topics: Anticholesteremic Agents; Atorvastatin; Bezafibrate; Coronary Disease; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Forearm; Heptanoic Acids; Humans; Hyperlipidemias; Image Interpretation, Computer-Assisted; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Myositis; Pyrroles | 2012 |
[Marked creatine-phosphokinase elevation in myopathy after treatment with bezafibrate].
Topics: Adult; Bezafibrate; Creatine Kinase; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Myositis | 2000 |
[Acute severe myositis due to bezafibrate treatment].
Topics: Acute Disease; Bezafibrate; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Kidney Diseases; Middle Aged; Myositis | 1989 |